InterMune, Inc. to Present at Canaccord Adams Hepatitis C Conference

BRISBANE, Calif., March 26 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq:ITMN - News) today announced that Scott Seiwert, Senior Vice President, Research and Technical Development of InterMune, will present at the Canaccord Adams Hepatitis C Conference in New York on April 1 at 11:15 a.m. EDT.
MORE ON THIS TOPIC